IATDMCT 2017

Presentation information

Print

Symposium

[S-2] S-2: TDM for the management of cancer therapy

Mon. Sep 25, 2017 10:30 AM - 12:00 PM Main Hall (1F)

Chairs: William Clarke, USA / Yuichi Ando, Japan

[S-2-1] Benefit of TDM depends on therapeutic class of anticancer drugs

Etienne Chatelut (Institut Universitaire du Cancer de Toulouse)

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

Password